206 related articles for article (PubMed ID: 28351163)
21. The effect of omalizumab on hematological and inflammatory parameters in patients with chronic spontaneous urticaria.
Acer E; Kaya Erdogan H; Yüksel Çanakçı N; Saracoglu ZN
Cutan Ocul Toxicol; 2019 Mar; 38(1):5-8. PubMed ID: 29969297
[TBL] [Abstract][Full Text] [Related]
22. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial.
Dakhale GN; Shinde AT; Mahatme MS; Hiware SK; Mishra DB; Mukhi JI; Salve AM
Int J Dermatol; 2014 May; 53(5):643-9. PubMed ID: 24320728
[TBL] [Abstract][Full Text] [Related]
23. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo.
Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK
Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
[TBL] [Abstract][Full Text] [Related]
25. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity.
Kiyici S; Gul OO; Baskan EB; Hacioglu S; Budak F; Erturk E; Imamoglu S
Clin Exp Dermatol; 2010 Aug; 35(6):603-7. PubMed ID: 19874329
[TBL] [Abstract][Full Text] [Related]
26. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study.
Weller K; Ardelean E; Scholz E; Martus P; Zuberbier T; Maurer M
Acta Derm Venereol; 2013 Mar; 93(2):168-74. PubMed ID: 23053062
[TBL] [Abstract][Full Text] [Related]
27. Association of ORAI1 gene polymorphisms with chronic spontaneous urticaria and the efficacy of the nonsedating H1 antihistamine desloratadine.
Li J; Guo A; Chen W; Bin L; He Y; Zhu W; Peng C; Yan S; Chen M; Zhang J; Su J; Yi M; Liu Z; Zhang W; Zeng W; Leung DY; Chen X
J Allergy Clin Immunol; 2017 Apr; 139(4):1386-1388.e9. PubMed ID: 27864023
[No Abstract] [Full Text] [Related]
28. Quality of life in adults with chronic idiopathic urticaria receiving desloratadine: a randomized, double-blind, multicentre, placebo-controlled study.
Grob JJ; Auquier P; Dreyfus I; Ortonne JP
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):87-93. PubMed ID: 18181978
[TBL] [Abstract][Full Text] [Related]
29. Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
Ring J; Hein R; Gauger A; Bronsky E; Miller B
Int J Dermatol; 2001 Jan; 40(1):72-6. PubMed ID: 11277962
[TBL] [Abstract][Full Text] [Related]
30. Elevated plasma il-8 concentration is related to severity of systemic inflammation in chronic spontaneous urticaria.
Kasperska-Zajac A; Grzanka A; Damasiewicz-Bodzek A; Bieniek K; Skrzypulec-Frankel A; Stencel-Gabriel K; Sikora-Zydek A
J Biol Regul Homeost Agents; 2017; 31(4):957-961. PubMed ID: 29254299
[TBL] [Abstract][Full Text] [Related]
31. H(1)-antihistamines and urticaria: how can we predict the best drug for our patient?
Church MK; Maurer M
Clin Exp Allergy; 2012 Oct; 42(10):1423-9. PubMed ID: 22994340
[TBL] [Abstract][Full Text] [Related]
32. Human H1 receptor (HRH1) gene polymorphism is associated with the severity of side effects after desloratadine treatment in Chinese patients with chronic spontaneous uticaria.
Li J; Chen W; Peng C; Zhu W; Liu Z; Zhang W; Su J; Li J; Chen X
Pharmacogenomics J; 2020 Feb; 20(1):87-93. PubMed ID: 31406237
[TBL] [Abstract][Full Text] [Related]
33. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
[TBL] [Abstract][Full Text] [Related]
34. Association of FCER1A genetic polymorphisms with risk for chronic spontaneous urticaria and efficacy of nonsedating H1-antihistamines in Chinese patients.
Guo A; Zhu W; Zhang C; Wen S; Chen X; Chen M; Zhang J; Su J; Chen W; Zhao Y; Yan S; He Y; Liu Z; Zhou H; Chen X; Li J
Arch Dermatol Res; 2015 Mar; 307(2):183-90. PubMed ID: 25412950
[TBL] [Abstract][Full Text] [Related]
35. Systematic review of treatments for chronic spontaneous urticaria with inadequate response to licensed first-line treatments.
Mitchell S; Balp MM; Samuel M; McBride D; Maurer M
Int J Dermatol; 2015 Sep; 54(9):1088-104. PubMed ID: 25515967
[TBL] [Abstract][Full Text] [Related]
36. CRP, D-dimer, fibrinogen and ESR as predictive markers of response to standard doses of levocetirizine in patients with chronic spontaneous urticaria.
Kolkhir P; Pogorelov D; Olisova O
Eur Ann Allergy Clin Immunol; 2017 Jul; 49(4):189-192. PubMed ID: 28752724
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic options in idiopathic chronic urticaria].
Mora PM; González Pérez Mdel C; Jiménez Villarruel M; Rodriguez Castro E; Fogelbach GG
Rev Alerg Mex; 2005; 52(2):77-82. PubMed ID: 16158780
[TBL] [Abstract][Full Text] [Related]
38. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
Yagami A; Furue M; Togawa M; Saito A; Hide M
J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Oxidative Stress and Antioxidant Status in Chronic Obstructive Pulmonary Disease.
Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
Scand J Immunol; 2017 Feb; 85(2):130-137. PubMed ID: 28256060
[TBL] [Abstract][Full Text] [Related]
40. Desloratidine for the treatment of chronic urticaria.
Monroe EW
Skin Therapy Lett; 2002 Oct; 7(8):1-2, 5. PubMed ID: 12548327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
